Fabio S. Santos
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
An Extended Flow Cytometry Evaluation of ex Vivo Expanded NK Cells Using K562.Clone1, a Feeder Cell Line Manufactured in Brazil.
Journal: Transplantation and cellular therapy
Published: March 12, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications.
Journal: Blood
Published: January 03, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Journal: Blood
Published: December 22, 2023
Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome-A propensity score matched analysis.
Journal: Hematology, transfusion and cell therapy
Published: June 28, 2023
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
Journal: NEJM evidence
Published: July 01, 2022
Molecular Characterization of a First-in-Human Clinical Response to Nimesulide in Acute Myeloid Leukemia.
Journal: Frontiers in oncology
Published: February 11, 2022
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Journal: Nature medicine
Published: May 05, 2021
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Journal: Nature medicine
Published: February 10, 2021
Targeted-dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial.
Journal: Hematological oncology
Published: October 10, 2019
Prognostic impact of RAS-pathway mutations in patients with myelofibrosis.
Journal: Leukemia
Published: April 29, 2019
Last Updated: 09/26/2026